Grant Opportunities, Professional Events 13 Jan 2025 health, epilepsy, cdc, public health, research, grants
Grant Opportunities, Professional Events 13 Jan 2025 health, diabetes prevention, grant opportunities, cdc, business initiatives
Compliance, Grant Opportunities, Healthcare 13 Jan 2025 nih, health, government regulation, parkinson's disease, compliance
Business Opportunities, Regulatory Compliance 13 Jan 2025 nih, health, grants, infectious diseases, contract proposals, business
Grant Opportunities, Health Initiatives 13 Jan 2025 health, grant opportunities, cdc, funding, business initiatives, diabetes
Grant Opportunities, Regulatory Compliance 13 Jan 2025 research funding, nih, health, grant opportunities, drug abuse
Grant Opportunities, Compliance, Regulatory Requirements 13 Jan 2025 nih, health, virtual meetings, funding, research, grants
Grant Opportunities, Professional Events 10 Jan 2025 funding, grant opportunities, nih, health, scientific review
Regulatory, Compliance 10 Jan 2025 compliance, health, human services, refugee resettlement, delegation of authority

📜2025 Amendment on Delegation of Authority for Refugee Resettlement

The Administration for Children and Families (ACF) is amending the Statement of Organization, Functions and Delegation of Authority ("Statement") issued in the Federal Register on April 28, 2009. The Statement delegated specific provisions of the William Wilberforce Trafficking Victims Protection Reauthorization Act of 2008, Public Law 110-457, section 235 from the Assistant Secretary for Children and Families to the Director of the Office of Refugee Resettlement. This amendment modifies the Statement to authorize the Director of the Office of Refugee Resettlement to redelegate the listed authorities contained within the Statement.

Learn More
Regulatory Compliance, Public Health Strategy 10 Jan 2025 business regulation, fda, health, food safety, public health, antimicrobial resistance

🏥FDA Seeks Comments for NARMS 2026-2030 Strategic Plan

The Food and Drug Administration (FDA, we, or Agency) is soliciting comments from the public regarding the National Antimicrobial Resistance Monitoring System (NARMS) 2026-2030 Strategic Plan. Comments received will help inform the development of a draft 2026-2030 Strategic Plan, to be discussed at a public meeting in spring 2025. Specific questions and information requests are included in this notice to help guide input from interested parties.

Learn More